Mouth Microbes and Pancreatic Cancer

The mix of bacteria living in the oral cavity is related to a person’s risk of developing pancreatic cancer, according to a study.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Infected periodontal biofilmWIKIMEDIA, MARK BONNER DMDPancreatic cancer is one of the most lethal and difficult-to-detect cancers, causing around 40,000 deaths per year in the U.S.—most within just six months of diagnosis. Now, a team led by researchers at New York University (NYU) has shown that the composition of bacteria living in the mouth is associated with a person’s risk of developing the disease, adding to existing evidence that oral health and pancreatic cancer are linked. The findings were reported yesterday (April 19) in New Orleans at the annual meeting of the American Association for Cancer Research.

“Our study offers the first direct evidence that specific changes in the microbial mix in the mouth—the oral microbiome—represent a likely risk factor for pancreatic cancer,” study coauthor Jiyoung Ahn of NYU said in a statement. “These bacterial changes in the mouth could potentially show us who is most at risk of developing pancreatic cancer.”

Previous studies had already suggested an association between poor oral health—for example, the presence of periodontal (gum) disease and the absence of teeth—and pancreatic cancer risk, but it remained unclear whether bacteria responsible for some of this poor oral health were involved. For the recent, 10-year study, the NYU-led team analyzed the bacterial contents in mouthwash samples from 361 Americans who later developed pancreatic cancer, along with those from 371 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies